Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD),
formerly known as Non- Alcoholic Fatty Liver Disease, is the most common cause of chronic liver disease in the world. This affects 25-30% of the world’s population, including over 50 million in our nation. It is now a leading indication
for liver transplantation.

​

MASLD is defined by fat in the liver affecting at least 5% of the liver cells, after other causes of liver fat have been ruled out such as significant alcohol use, viral infections and certain medications.

​

Our goal is to find this disease early by knowing who to screen, then aim for complete reversal of the fat in the liver, before it progresses to advanced disease.
To date, we have documented dozens of patients with remission of their fatty liver,
as measured by liver scan.​